OAS3 Antikörper (AA 424-565) (HRP)
-
- Target Alle OAS3 Antikörper anzeigen
- OAS3 (2'-5' Oligoadenylate Synthetase 3 (OAS3))
-
Bindungsspezifität
- AA 424-565
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser OAS3 Antikörper ist konjugiert mit HRP
-
Applikation
- ELISA
- Kreuzreaktivität
- Human
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human 2\'-5\'-oligoadenylate synthase 3 protein (424-565AA)
- Isotyp
- IgG
- Top Product
- Discover our top product OAS3 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- OAS3 (2'-5' Oligoadenylate Synthetase 3 (OAS3))
- Andere Bezeichnung
- OAS3 (OAS3 Produkte)
- Synonyme
- p100 antikoerper, Oasl10 antikoerper, 2'-5'-oligoadenylate synthetase 3 antikoerper, 2'-5' oligoadenylate synthetase 3 antikoerper, OAS3 antikoerper, Oas3 antikoerper
- Hintergrund
-
Background: Interferon-induced, dsRNA-activated antiviral enzyme which plays a critical role in cellular innate antiviral response. In addition, it may also play a role in other cellular processes such as apoptosis, cell growth, differentiation and gene regulation. Synthesizes preferentially dimers of 2\'-5\'-oligoadenylates (2-5A) from ATP which then bind to the inactive monomeric form of ribonuclease L (RNase L) leading to its dimerization and subsequent activation. Activation of RNase L leads to degradation of cellular as well as viral RNA, resulting in the inhibition of protein synthesis, thus terminating viral replication. Can mediate the antiviral effect via the classical RNase L-dependent pathway or an alternative antiviral pathway independent of RNase L. Displays antiviral activity against Chikungunya virus (CHIKV), Dengue virus, Sindbis virus (SINV) and Semliki forest virus (SFV).
Aliases: (2-5'')oligo(A) synthase 3 antibody, 2 5' oligo(A) synthetase 3 antibody, 2 5'LIGO antibody, 2 5A synthetase 3 antibody, 2''-5''-oligoadenylate synthase 3 antibody, 2-5A synthase 3 antibody, MGC133260 antibody, OAS3 2' 5' oligoadenylate synthetase 3, 100 kDa antibody, OAS3 antibody, OAS3_HUMAN antibody, p100 antibody, p100 OAS antibody, p100OAS antibody
- UniProt
- Q9Y6K5
- Pathways
- Hepatitis C
-